Biosynex SA (EPA:ALBIO)
France · Delayed Price · Currency is EUR 0.9200
+0.0160 (1.77%)
Jul 31, 2026, 11:05 AM CET
Biosynex Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 95.19 | 101.17 | 69.86 | 138.6 | 237.3 | |
Revenue Growth | -5.90% | 44.82% | -49.60% | -41.59% | 54.20% |
Cost of Revenue | 42.84 | 43.75 | 35.66 | 68.07 | 123.02 |
Gross Profit | 52.36 | 57.42 | 34.2 | 70.53 | 114.28 |
Selling, General & Admin | 63.79 | 80.26 | 47.22 | 45.69 | 42.19 |
Depreciation & Amortization Expenses | 55.83 | 36.32 | 15.15 | 5.92 | 4.56 |
Other Operating Expenses | -19.94 | -22.82 | -10.22 | -6.13 | -3.11 |
Total Operating Expenses | 99.68 | 93.76 | 52.15 | 45.48 | 43.64 |
Operating Income | -47.33 | -36.33 | -17.96 | 25.05 | 70.64 |
Interest Income | - | - | 50.4 | 28.86 | 7.97 |
Interest Expense | - | - | -10.3 | -13.73 | -2.69 |
Other Non-Operating Income (Expense) | -11.74 | -8.32 | 2.23 | -4.85 | -3.18 |
Total Non-Operating Income (Expense) | -11.74 | -8.32 | 42.32 | 10.28 | 2.09 |
Pretax Income | -59.07 | -44.65 | 24.37 | 35.34 | 72.73 |
Provision for Income Taxes | -1.1 | -1.36 | -0.5 | 4.5 | 17.79 |
Net Income | -57.97 | -43.3 | 24.87 | 30.84 | 54.94 |
Minority Interest in Earnings | 0.25 | 0.03 | - | - | - |
Net Income to Common | -58.22 | -43.33 | 24.87 | 30.84 | 54.94 |
Net Income Growth | - | - | -19.35% | -43.87% | 75.14% |
Shares Outstanding (Basic) | 19 | 11 | 10 | 20 | 5 |
Shares Outstanding (Diluted) | 19 | 11 | 10 | 20 | 5 |
Shares Change | 74.11% | 7.56% | -50.73% | 269.67% | -46.71% |
EPS (Basic) | -3.11 | -4.03 | -3.45 | 1.53 | 10.08 |
EPS (Diluted) | -3.11 | -4.03 | -3.45 | 1.52 | 10.01 |
EPS Growth | - | - | - | -84.81% | 228.20% |
Free Cash Flow | -8.57 | -14.96 | -49.2 | -32.83 | 90.82 |
Free Cash Flow Growth | - | - | - | - | 303.29% |
Free Cash Flow Per Share | -0.46 | -1.39 | -4.92 | -1.62 | 16.55 |
Dividends Per Share | - | - | - | - | 2.000 |
Dividend Growth | - | - | - | - | 900.00% |
Gross Margin | 55.00% | 56.76% | 48.95% | 50.89% | 48.16% |
Operating Margin | -49.72% | -35.91% | -25.70% | 18.08% | 29.77% |
Profit Margin | -60.90% | -42.80% | 35.61% | 22.25% | 23.15% |
FCF Margin | -9.01% | -14.79% | -70.43% | -23.68% | 38.27% |
EBITDA | 5.61 | -15.8 | -4.5 | 46.42 | 72.68 |
EBITDA Margin | 5.89% | -15.62% | -6.44% | 33.49% | 30.63% |
EBIT | -47.33 | -36.33 | -17.96 | 25.05 | 70.64 |
EBIT Margin | -49.72% | -35.91% | -25.70% | 18.08% | 29.77% |
Effective Tax Rate | 1.86% | 3.03% | -2.07% | 12.72% | 24.46% |